Armata Pharmaceuticals, Inc. (ARMP) › Operating Cash FlowArmata Pharmaceuticals, Inc. (ARMP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$10.61M2017: -$9.19M2018: -$10.63M2019: -$15.58M2020: -$18.27M2021: -$23.57M2022: -$32.48M2023: -$47.42M2024: -$37.55M2025: -$25.76M-$25.76M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$25.76M+31.4%2024-$37.55M+20.8%2023-$47.42M-46.0%2022-$32.48M-37.8%2021-$23.57M-29.0%2020-$18.27M-17.3%2019-$15.58M-46.6%2018-$10.63M-15.6%2017-$9.19M+13.3%2016-$10.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share